01 2Pierre Fabre Dermo Cosmetique
02 1Pierre Fabre Dermo-Cosmetique
03 3Pierre Fabre Medicament
04 3Pierre Fabre Pharmaceuticals, Inc.
01 1No Action Indicated
02 8Voluntary Action Indicated
01 12024-11-01
02 12022-07-27
03 12019-09-20
04 12018-07-13
05 12016-04-15
06 12015-12-30
07 22015-01-16
08 12013-03-14
01 3Avene
02 3Gaillac
03 3Parsippany
01 6France
02 3U.S.A
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-11-01
City : Parsippany
State : New Jersey
Country/Area : U.S.A
Zip : 7054
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-11-01
District Decision : Voluntary Action Indicated
Inspection End Date : 2022-07-27
City : Parsippany
State : New Jersey
Country/Area : U.S.A
Zip : 7054
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2022-07-27
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-20
City : Avene
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-20
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-07-13
City : Gaillac
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-07-13
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-04-15
City : Gaillac
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-04-15
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-12-30
City : Parsippany
State : New Jersey
Country/Area : U.S.A
Zip : 7054
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-12-30
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
City : Avene
State :
Country/Area : France
Zip :
District : ORA
Center : CFSAN
Project Area : Colors and Cosmetics Technology
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
City : Avene
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
District Decision : No Action Indicated
Inspection End Date : 2013-03-14
City : Gaillac
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2013-03-14
Pierre Fabre is a supplier offers 16 products (APIs, Excipients or Intermediates).
Find Vinorelbine Tartrate bulk with DMF, CEP, JDMF offered by Pierre Fabre
Find Milnacipran Hydrochloride bulk with DMF, JDMF offered by Pierre Fabre
Find Chondroitin Sulfate Sodium bulk with CEP offered by Pierre Fabre
Find Ciclopirox bulk offered by Pierre Fabre
Find HYDROXYPROPYLMETHYLCELLULOSE bulk with CEP offered by Pierre Fabre
Find Levomilnacipran bulk with DMF offered by Pierre Fabre
Find Vinflunine Ditartrate bulk with DMF offered by Pierre Fabre
Find Mucoproteose bulk with CEP offered by Pierre Fabre
Find Ciclopirox Olamine bulk offered by Pierre Fabre
Find HYDROXYPROPYLMETHYLCELLULOSE bulk offered by Pierre Fabre
Find Idazoxan bulk offered by Pierre Fabre
Find Milnacipran Hydrochloride bulk offered by Pierre Fabre
Find Vinflunine Ditartrate bulk offered by Pierre Fabre
Find Vinorelbine Tartrate bulk offered by Pierre Fabre
Find MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GAILLAC, FRANCE. bulk offered by Pierre Fabre
Find Navelbine Tartrate bulk offered by Pierre Fabre
